Baek et al. investigated the duration of COVID-19 virus shedding in infected patients and demonstrated that even in patients demonstrating prolonged viral clearance, the virus was no longer viable after 15 days post onset of symptoms. Our study aimed to measure whether nitric oxide nasal spray (NONS) further accelerates this reduction in SARS-CoV-2 RNA load versus a control arm with saline spray. Our study recruited 80 participants who were divided into a NONS treatment arm or a placebo arm to test the efficacy of NONS as a treatment for mild COVID-19 infection.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117664 | PMC |
| http://dx.doi.org/10.1016/j.jinf.2021.05.009 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Editor's Roundup: Known Knowns, Known Unknowns, and Unknown Unknowns in ECT--Due Diligence and Preparation Are Sine Qua Nons of Practice; Machine Learning to Refine and Inform ECT Practice; the CARE Network Helps Drive Better Understanding of Treatment Variation to Improve Outcomes, Practice, Education, and Policy, Among Other Uses; Advocacy for ECT in Guidelines and in the Arts-A Reminder of Our Role.
J ECT
December 2024
From the University of Washington School of Medicine, Seattle, WA.
Nitric oxide-based multi-synergistic nanomedicine: an emerging therapeutic for anticancer.
J Nanobiotechnology
November 2024
College of Pharmaceutical Sciences, Southwest University, Chongqing, 400715, China.
Gas therapy has emerged as a promising approach for treating cancer, with gases like NO, HS, and CO showing positive effects. Among these, NO is considered a key gas molecule with significant potential in stopping cancer progression. However, due to its high reactivity and short half-life, delivering NO directly to tumors is crucial for enhancing cancer treatment.
View Article and Find Full Text PDFAstodrimer sodium nasal spray forms a barrier to SARS-CoV-2 in vitro and preserves normal mucociliary function in human nasal epithelium.
Sci Rep
September 2024
Starpharma Pty Ltd, Abbotsford, VIC, 3067, Australia.
COVID-19 remains a severe condition for many including immunocompromised individuals. There remains a need for effective measures against this and other respiratory infections, which transmit via virus-laden droplets that reach the nasal or oral mucosae. Nasal sprays offer potential protection against viruses.
View Article and Find Full Text PDFAntibody Fc receptor binding and T cell responses to homologous and heterologous immunization with inactivated or mRNA vaccines against SARS-CoV-2.
Nat Commun
August 2024
HKU-Pasteur Research Pole, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.
Whole virion inactivated vaccine CoronaVac (C) and Spike (S) mRNA BNT162b2 (B) vaccines differ greatly in their ability to elicit neutralizing antibodies but have somewhat comparable effectiveness in protecting from severe COVID-19. We conducted further analyses for a randomized trial (Cobovax study, NCT05057169) of third dose homologous and heterologous booster vaccination, i.e.
View Article and Find Full Text PDFGram-negative bacterial infections in surgical intensive care unit patients following abdominal surgery: high mortality associated with Stenotrophomonas maltophilia infection.
Antimicrob Resist Infect Control
June 2024
Chang Gung University College of Medicine, Taoyuan, Taiwan.
Background: Stenotrophomonas maltophilia, a multidrug-resistant gram-negative bacteria (GNB), is an emerging nosocomial pathogen. This study assessed the clinical outcomes of GNB infections in surgical intensive care unit (SICU) patients post-abdominal surgery, focusing on the differences between S. maltophilia and other GNBs, including Pseudomonas aeruginosa.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!